Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management (Faculty Presentations)Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management (Faculty Presentations)
Hans Lee, MD
Associate Professor Director, Multiple Myeloma Clinical Research Department of Lymphoma/Myeloma The University of Texas MD Anderson Cancer Center Houston, Texas Saad Zafar Usmani, MD, MBA |